These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16950380)

  • 41. Pharmacologic interventions for psychosis and agitation in neurodegenerative diseases: evidence about efficacy and safety.
    Weintraub D; Katz IR
    Psychiatr Clin North Am; 2005 Dec; 28(4):941-83, ix-x. PubMed ID: 16325736
    [No Abstract]   [Full Text] [Related]  

  • 42. A naturalistic study of consecutive agitated emergency department patients treated with intramuscular olanzapine prior to consent.
    Damsa C; Adam E; Lazignac C; Mihai A; DE Gregorio F; Lejeune J; Maris S; Clivaz E; Allen MH
    Am J Psychiatry; 2008 Apr; 165(4):535-6. PubMed ID: 18381919
    [No Abstract]   [Full Text] [Related]  

  • 43. A review of agitation in mental illness: treatment guidelines and current therapies.
    Marder SR
    J Clin Psychiatry; 2006; 67 Suppl 10():13-21. PubMed ID: 16965191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
    Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
    Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clozapine for treatment-resistant agitation in dementia.
    Lee HB; Hanner JA; Yokley JL; Appleby B; Hurowitz L; Lyketsos CG
    J Geriatr Psychiatry Neurol; 2007 Sep; 20(3):178-82. PubMed ID: 17712102
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sedation--therapeutic or side effect in psychoses. Introduction.
    Miller DD
    Pharmacotherapy; 1996; 16(6 Pt 2):141S-142S. PubMed ID: 8947996
    [No Abstract]   [Full Text] [Related]  

  • 47. The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes--a 12-month follow-up study.
    Selbaek G; Kirkevold Ø; Engedal K
    Am J Geriatr Psychiatry; 2008 Jul; 16(7):528-36. PubMed ID: 18591573
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients.
    Kissling W; Glue P; Medori R; Simpson S
    Hum Psychopharmacol; 2007 Dec; 22(8):505-13. PubMed ID: 17902187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Practical limitations of prescribing olanzapine depot (Relprevv).
    Devadason P
    Australas Psychiatry; 2010 Jun; 18(3):269. PubMed ID: 20482436
    [No Abstract]   [Full Text] [Related]  

  • 50. Epidemiology and characteristics of emergency departments visits by US adults with psychiatric disorder and antipsychotic mention from 2000 to 2004.
    Sankaranarayanan J; Puumala SE
    Curr Med Res Opin; 2007 Jun; 23(6):1375-85. PubMed ID: 17594776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Benzodiazepines and acute psychotic agitation.
    Benazzi F; Mazzoli M; Rossi E
    Can J Psychiatry; 1992 Dec; 37(10):732-3. PubMed ID: 1361879
    [No Abstract]   [Full Text] [Related]  

  • 52. Effectiveness of Intramuscular Chlorpromazine for Rapid Treatment of Psychomotor Agitation: A Naturalistic, Retrospective, and Observational Study.
    Cuomo A; Chioccioli M; Cattaneo CI; Magnani PA; Bussolotti D; Larcinese R; Bruni A; Torti C; Fagiolini A
    J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):613-614. PubMed ID: 34155163
    [No Abstract]   [Full Text] [Related]  

  • 53. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to make the decision to resort to an APAP)].
    Chéreau I; Gorwood P; Mouchabac S
    Encephale; 2009 Jan; Suppl 3():S97-100. PubMed ID: 19268186
    [No Abstract]   [Full Text] [Related]  

  • 55. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP].
    Buis C; Gourion D; Vaiva G
    Encephale; 2009 Jan; Suppl 3():S91-5. PubMed ID: 19268185
    [No Abstract]   [Full Text] [Related]  

  • 56. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Position of Canadian psychiatry].
    Stip E
    Encephale; 2009 Jan; Suppl 3():S115-8. PubMed ID: 19268180
    [No Abstract]   [Full Text] [Related]  

  • 57. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. First generation antipsychotic-induced severe hypothermia: A case report and review of the literature.
    Elbakary NAH; Ouanes S
    Asian J Psychiatr; 2019 Aug; 44():35-37. PubMed ID: 31306860
    [No Abstract]   [Full Text] [Related]  

  • 60. Impact of depressive mixed state in an emergency psychiatry setting: a marker of bipolar disorder and a possible risk factor for emergency hospitalization.
    Takeshima M; Kitamura T; Kitamura M; Kidani T; Tochimoto S; Muramori F; Kosaka K; Hasegawa M; Ueno K; Hamahara S; Kurata K
    J Affect Disord; 2008 Nov; 111(1):52-60. PubMed ID: 18355924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.